14th European Congress of Clinical Microbiology and Infectious ...

Poster Sessions Sunday, May 2, 2004
12:00–13:00
Community-acquired infections:
focus on unusual epidemics and update on
S. pneumoniae
P430 Community-acquired pneumonia caused by
“atypical” pathogens: clinical discrimination
with a predictive model and scoring system
M. Masiá, F. Gutiérrez, J.C. Rodríguez, S. Padilla,
G. Royo, J.M. Ramos, A. Ayelo, A. Martín-Hidalgo
(Elche, Alicante, E)
P431 Effects of a pneumococcal vaccination
programme in adult invasive Streptococcus
pneumoniae disease: a three-year experience
F.J. Vasallo, A. González-Escalada, V. del Campo,
S. Pérez, J. Torres (Vigo, E)
P432 Effect of initial treatment on bacteraemic
Streptococcus pneumoniae pneumonia
(BSPP) mortality
V. Pintado, R. Blazquez, E. Loza, J. Cobo,
J. Fortun, E. Navas, C. Quereda, S. Moreno
(Madrid, E)
P433 Comparative, randomised, open, multicentre
trial assessing the efficacy and safety of
intravenous/oral azithromycin compared to
intravenous/oral clarithromycin for the
treatment of community-acquired pneumonia
due to Legionella pneumophila
J. Roig, M. Sabriá, J. Alegre, M. Gurgui, J.C. Checa –
Spanish Study Group for Legionella
P434 Pseudomonas aeruginosa as a risk factor in
acute exacerbations of COPD
M. Allewelt, S. Balk, H. Lode (Berlin, D)
P435 Community outbreak of Legionella in
Hospitalet (Spain). Usefulness of the
epidemiological and molecular data to
identify the source
I. Barrabeig, M. Garcia-Nuñez, A. Dominguez,
A. Rovira, S. Ragull, A. Pedrol, J.M. Elorza,
M.L. Pedro-Botet, N. Sopena, M. Sabria
(Barcelona, Badalona, E)
P436 Significance of early Mycoplasma pneumoniae
serodiagnosis in hospitalised patients with
community-acquired pneumonia
A. Kuhnke, M. Bender, M. Allewelt, A. Roth,
H. Mauch, H. Lode (Berlin, D)
P437 Prevalence and degree of Legionella
colonisation in cooling towers
M. Garcia-Nuñez, S. Ragull, E. Junyent,
M.L. Pedro-Botet, N. Sopena, M. Sabria
(Badalona, E)
P438 Epidemiology of community-acquired
pneumonia revisited: a large population-based
prospective study in the Mediterranean coast
of Spain
F. Gutiérrez, M. Masiá, J.C. Rodríguez, S. Padilla,
G. Royo, J.M. Ramos, A. Ayelo, A. Martín-Hidalgo
(Elche, Alicante, E)
P439 Factors influencing treatment outcome and
length of stay in patients hospitalised for
community-acquired pneumonia
A. Neiss, D. Elkharrat, S. Kohno, J. Schentag,
S. Decker-Burgard, K. Roscher
(Munich, D; Paris, F; Nagasaki, JP; Buffalo, USA;
Bad Soden am Taunus, D)
P440 Bacteriological outcomes in hospitalised
patients with community-acquired pneumonia
treated with IV azithromycin plus ceftriaxone
versus IV ceftriaxone plus clarithromycin or
erythromycin
M. Tamm, T. Todisco, P.A. Willcox, F. Carrillo,
S. Fisher, P.J. de Caprariis, F. Blasi, I.M. Hoepelman
(Basle, CH; Perugia, I; Cape Town, ZA;
Guadalajara, E; New York, USA; Milan, I;
Utrecht, NL)
P441 First post-marketing data on treatment of
community-acquired pneumonia with
moxifloxacin i.v.
J. Barth, H. Landen, K. Stauch
(Halle/Saale, Leverkusen, D)
P442 Atypical pathogens in pathogenesis of
bronchial asthma in children and efficacy of
azithromycin as a part of complex therapy
O. Lasitsa, I. Ochotnicova, S. Lomonosov
(Kyiv, UKR)
P443 Management of community-acquired
pneumonia in a hospital in Norway:
penicillin still works!
B. Waldum, A. Bucher (Oslo, N)
P444 A case-control study on acute respiratory
infections of patients in general practices in
the Netherlands, October 2000 – September
2003
A.B. van Gageldonk-Lafeber, A. Bartelds,
M-L.H. Heijnen, M. Peeters, S.M. van der Plas,
S.C. de Greeff, B. Wilbrink
(Bilthoven, Utrecht, Tilburg, NL)
P445 Hospitalised community-acquired pneumonia:
characteristics, aetiology and outcome
É. Székely, C. Kósa, Z. Várnai, E. Ludwig
(Budapest, HUN)
www.escmid.org/eccmid2004
page 65